首页> 外文OA文献 >First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study

【2h】

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study

机译：一线化疗治疗恶性周围神经鞘瘤（MPNST）与其他组织学软组织肉瘤亚型以及MPNST的预后因素：EORTC软组织和骨肉瘤小组研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The role of chemotherapy in advanced malignant peripheral nerve sheath tumor (MPNST) is unclear.

机译：背景：化疗在晚期恶性周围神经鞘瘤（MPNST）中的作用尚不清楚。

著录项

作者
Kroep, J. R.; Ouali, M.; Gelderblom, H.; Le Cesne, A.; Dekker, T. J. A.; Van Glabbeke, M.; Hogendoorn, P. C. W.; Hohenberger, P.;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study. [J] . Kroep JR, Ouali M, Gelderblom H, Annals of oncology: official journal of the European Society for Medical Oncology . 2011,第1期

机译：一线化疗治疗恶性周围神经鞘瘤（MPNST）与其他组织学软组织肉瘤亚型以及作为MPNST的预后因素：EORTC软组织和骨肉瘤组研究。
2. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoman subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study [J] . P. Hohenberger Annals of Oncology . 2011,第1期

机译：一线化疗治疗恶性周围神经鞘瘤（MPNST）与其他组织学软组织肉瘤亚型以及作为MPNST的预后因素：EORTC软组织和骨肉瘤小组研究
3. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) [J] . Lindner Lars H., Litiere Saskia, Sleijfer Stefan, International Journal of Cancer =: Journal International du Cancer . 2018,第12期

机译：软组织肉瘤患者肺转移患者的预后因素仅接受一线化疗，探讨欧洲癌症软组织和骨肉瘤组研究和治疗组织的探索性，回顾性分析（EORTC-STBSG）
4. OPTIMIZING METRONOMIC CHEMOTHERAPY USING TUMOR BIOMARKERS IN DOGS WITH SOFT TISSUE SARCOMA [C] . Jenna Burton, Dahlia Rice, Jesse Harper, Annual Conference of the Veterinary Cancer Society . 2009

机译：用软组织肉瘤患者肿瘤生物标志物优化元组化疗
5. RABL6A Signaling as an Oncogenic Driver and Therapeutic Target in Malignant Peripheral Nerve Sheath Tumors (MPNST) [D] . Kohlmeyer, Jordan L. 2021

机译：Rabl6a以恶性外周神经鞘肿瘤（MPNST）为致癌驾驶员和治疗靶标
6. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study [O] . J. R. Kroep, M. Ouali, H. Gelderblom, -1

机译：一线化疗治疗恶性周围神经鞘瘤（MPNST）与其他组织学软组织肉瘤亚型以及MPNST的预后因素：EORTC软组织和骨肉瘤小组研究
7. Malignant peripheral nerve sheath tumour (MPNST) of thorax: a rare soft tissue sarcoma in a patient with neurofibromatosis type 1 [O] . S. Thanancheyan, A. Muthulingam, N. Selvaratnam 2021

机译：胸部的恶性外周神经鞘瘤（MPNST）：患有神经纤维瘤病患者的罕见软组织肉瘤1
8. Convection-Enhanced Delivery (CED) in an Animal Model of Malignant Peripheral Nerve Sheath (MPNST) Tumors and Plexiform Neurofibromas (PN). [R] . Yohay, K. 2012

机译：在恶性周围神经鞘（mpNsT）肿瘤和丛状神经纤维瘤（pN）的动物模型中的对流增强递送（CED）。

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study

摘要

著录项

相似文献

相关主题

期刊订阅